Search Results 371-380 of 13319 for bronchiolitis

  1. Aortic aneurysm - Doctors and departments - Mayo Clinic

    ... bronchiolitis obliterans syndrome, Anomalous aortic origin of the coronary artery, Cardiac complication of cancer treatment, Bicuspid aortic valve ...

  2. Pneumonia - Doctors and departments - Mayo Clinic

    ... Bronchiolitis, Myocarditis, Neuropathy, Cystitis, Syncope, Ischemic stroke, Venous stasis, Diabetic foot ulcer, Cellulitis, Osteomyelitis, Subdural ...

  3. Myocarditis - Doctors and departments - Mayo Clinic

    ... bronchiolitis obliterans syndrome, Pulmonary arteriovenous malformation, Anomalous aortic origin of the coronary artery, Cardiac complication of cancer ...

  4. Untitled

    Page 1.

  5. Alpha-1-antitrypsin deficiency - Symptoms and causes - Mayo Clinic

    Learn about the symptoms and risk factors of alpha-1-antitrypsin deficiency, a condition passed down in families, that can affect the lungs, liver or both.

  6. Respiratory Syncytial Virus Disease in Adults with High-Risk Conditions in North American Communities - Mayo Clinic

    The primary purpose of this study is to estimate the incidence rate of confirmed respiratory syncytial virus (RSV) (and other confirmed respiratory viruses) ...

  7. Interstitial lung disease - Doctors and departments - Mayo Clinic

    ... bronchiolitis obliterans syndrome, Anomalous aortic origin of the coronary artery, Cardiac complication of cancer treatment, Bicuspid aortic valve ...

  8. Coronary artery disease - Doctors and departments - Mayo Clinic

    ... bronchiolitis obliterans syndrome, Anomalous aortic origin of the coronary artery, Cardiac complication of cancer treatment, Bicuspid aortic valve ...

  9. Nasal congestion - Mayo Clinic

    Bronchiolitis · Chronic cough · Chronic daily headaches · Chronic sinusitis · Cluster headache · Cold and flu viruses: How long can they live outside the body?

  10. Mycobacterium Avium Complex Pulmonary Infections Systems Biology to Predict Progression and Treatment - Mayo Clinic

    The purpose of this study is to develop two quantitative risk scores for MAC-PD that computationally integrates clinical, immunological, and pharmacological ...